Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-05 Other |
2025-02-27 6:51 pm |
N/A N/A |
Tonix Pharmaceuticals Holding Corp. | TNXP | SAENGER BRADLEY Chief Financial Officer |
0 | $0 | 51,584 (Direct) |
View |
| 2025-02-25 Option Award |
2025-02-27 6:51 pm |
2026-02-25 2035-02-25 |
Tonix Pharmaceuticals Holding Corp. | TNXP | SAENGER BRADLEY Chief Financial Officer |
51,584 | $0 | 51,584 (Direct) |
View |
| 2024-02-27 Option Award |
2024-02-29 5:07 pm |
2025-02-27 2034-02-27 |
Tonix Pharmaceuticals Holding Corp. | TNXP | SAENGER BRADLEY Chief Financial Officer |
564,000 | $0 | 564,000 (Direct) |
View |
| 2023-02-23 Option Award |
2023-02-24 6:37 pm |
2024-02-23 2033-02-23 |
Tonix Pharmaceuticals Holding Corp. | TNXP | SAENGER BRADLEY Chief Financial Officer |
400,000 | $0 | 400,000 (Direct) |
View |
| 2022-02-15 Option Award |
2022-02-17 5:19 pm |
2023-02-15 2032-02-15 |
Tonix Pharmaceuticals Holding Corp. | TNXP | SAENGER BRADLEY Chief Financial Officer |
3,600,000 | $0 | 3,600,000 (Direct) |
View |
| 2021-06-30 Ownership |
2022-02-11 5:18 pm |
N/A N/A |
Tonix Pharmaceuticals Holding Corp. | TNXP | SAENGER BRADLEY Chief Financial Officer |
18,248 | $0.58 | 19,645 (Direct) |
View |
| 2021-02-23 Option Award |
2021-02-25 5:52 pm |
2022-02-23 2031-02-23 |
Tonix Pharmaceuticals Holding Corp. | TNXP | SAENGER BRADLEY Chief Financial Officer |
1,080,000 | $0 | 1,080,000 (Direct) |
View |
| 2020-01-06 Ownership |
2021-02-12 5:32 pm |
N/A N/A |
Tonix Pharmaceuticals Holding Corp. | TNXP | SAENGER BRADLEY Chief Financial Officer |
493 | $1.02 | 1,397 (Direct) |
View |
| 2020-05-04 Option Award |
2020-05-06 6:26 pm |
2021-05-04 2030-05-04 |
Tonix Pharmaceuticals Holding Corp. | TNXP | SAENGER BRADLEY Chief Financial Officer |
720,000 | $0 | 720,000 (Direct) |
View |